International Stem Cell CORP
ISCO· OTC
ISCOInternational Stem Cell CORP
Released Nov 14, 2022, after the close
10-Q filed Nov 14, 2022, 45 days after period end · 0001564590-22-037618
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2022 | Q3 2021 | Q3 2020 | Q3 2019 |
|---|---|---|---|---|
| Revenue | $1.70M | $1.84M | $1.48M | $2.10M |
| Net Income | -$343.00K | -$165.00K | -$544.00K | $3.00K |
| EPS Diluted | -$0.04 |
International Stem Cell CORP · CIK 1355790 · Engraved from SEC EDGAR
| -$0.02 |
| -$0.07 |
| $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
